GBP/USD Is At Risk Of Extending Its Decline As It's Pressuring The 1.4110 Support

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

GBP/USD Current price: 1.4112

• BOE’s Andy Haldane warned about rising inflationary pressures, called on cutting back stimulus.
• UK new coronavirus cases at their highest since mid-February amid Delta strain.
• GBP/USD is at risk of extending its decline as it’s pressuring the 1.4110 support.

The GBP/USD pair neared the 1.4200 figure but took a turn to the worse during the American session, now trading a few pips above the 1.4100 level, with the decline exacerbated by coronavirus-related concerns. UK epidemiologist Neil Ferguson said that the UK could see a third wave comparable to the second one in terms of hospitalizations, if not deaths. The new Delta strain, currently the dominant in the UK, is believed to be 60% more transmissible than the Alpha one. The UK reported over 7,500 new cases in the past 24 hours, the biggest one-day increase since February 17.

Earlier in the day, Bank of England Chief Economist Andy Haldane warned about rising inflationary pressures and called on cutting back stimulus amid a roaring economy. The UK macroeconomic calendar had nothing to offer this Wednesday.  On Thursday, the country will publish the May RICS Housing Price Balance.

GBP/USD Short-Term Technical Outlook

The GBP/USD pair is at risk of falling further, as it consolidates losses around 1.4115. The near-term picture is bearish, as the pair was unable to advance beyond its 20 and 100 SMAs, both converging around 1.4165. Technical indicators head south within negative levels, with the Momentum heading firmly lower and the RSI decelerating at around 41. A test of the 1.4000 threshold is on the card for this Thursday, while sellers will likely keep defending the 1.4200 price zone.

Support levels: 1.4110 1.4070 1.4020

Resistance levels: 1.4165 1.4210 1.4250

Image Sourced from Pixabay

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.